Cooper Companies Inc
Change company Symbol lookup
Select an option...
COO Cooper Companies Inc
QOMOU Qomolangma Acquisition Corp
NOMD Nomad Foods Ltd
LII Lennox International Inc
XPEV Xpeng Inc
SCHW-J Charles Schwab Corp
BIOT Biotech Acquisition Co
MICR Micron Solutions Inc
WSBF Waterstone Financial Inc
MBRX Moleculin Biotech Inc
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Blend
Company profile

The Cooper Companies, Inc. global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. CooperVision is a manufacturer providing products for contact lens wearers. It develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses. It designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. It also offers contact lenses in a variety of materials, including silicone hydrogel Aquaform technology, and others. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. Its products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists; and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.

Closing Price
$263.90
Day's Change
-5.50 (-2.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
274.54
Day's Low
263.68
Volume
(Heavy Day)
Volume:
400,404

10-day average volume:
332,087
400,404

Company Profile

The Cooper Companies, Inc. global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. CooperVision is a manufacturer providing products for contact lens wearers. It develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses. It designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. It also offers contact lenses in a variety of materials, including silicone hydrogel Aquaform technology, and others. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. Its products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists; and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.

Valuation Ratios

Price/Earnings (TTM)
31.13x
Price/Sales (TTM)
4.12x
Price/Book (MRQ)
1.87x
Price/Cash Flow (TTM)
17.35x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

September 2022
Current Month
1.2M
Previous Month
1.3M
Percent of Float
2.35%
Days to Cover
3.3003 Days

Share Information

COO is in a share class of common stock
Float
49.1M
Shares Outstanding
49.3M
Institutions Holding Shares
851
103.69%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Robert S. Weiss
  • Albert G. WhitePres.
  • Brian George AndrewsCFO
  • Holly R. SheffieldCorp.Exec.
  • Gerard H, WarnerCorp.Exec.

Address

Insider Trading

During the most recent quarter, 14K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.